Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
South Asian Journal of Cancer|December 25, 2025
Safety of Abemaciclib in Indian Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced and/or Metastatic Breast Cancer: A Multicenter, Nonrandomized, Open-Label, Single-Arm, Phase 4 StudyDinesh Chandra Doval, Tanveer Maksud, Rajnish Nagarkar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2008
Clinical experience with gefitinib in Indian patientsPurvish Parikh, Alex Yuang-Chi Chang, Shona Nag, et al.
Scientific Reports|April 5, 2020
A multi-institutional real world data study from India of 3453 non-metastatic breast cancer patients undergoing upfront surgeryDinesh Chandra Doval, Selvi Radhakrishna, Rupal Tripathi, et al.
Breast (Edinburgh, Scotland)|June 7, 2021
The usefulness of CanAssist breast in the assessment of recurrence risk in patients of ethnic Indian originDinesh Chandra Doval, Anurag Mehta, S P Somashekhar, et al.
Medical Oncology (Northwood, London, England)|November 18, 2021
Detection of human papillomavirus infection in oral cancers reported at dental facility: assessing the utility of FFPE tissuesGaurav Verma, Nikita Aggarwal, Suhail Chhakara, et al.
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|May 5, 2017
Indian Council of Medical Research Consensus Document for the Management of Non-Hodgkin's Lymphoma (High Grade)Dinesh Chandra Doval, Dinesh Bhurani, Reena Nair, et al.
Journal of Gastrointestinal Cancer|December 3, 2025
Clinical Efficacy and Safety of Gemcitabine-Cisplatin Combination in Metastatic Gallbladder Cancer: A Prospective Study from North IndiaAbhinav Dewan, Vineet Talwar, Varun Goel, et al.
American Journal of Cancer Research|July 25, 2014
Distinct breast cancer subtypes in women with early-onset disease across racesMandeep Singh, Yi Ding, Li-Ying Zhang, et al.
Clinical Colorectal Cancer|October 27, 2016
Efficacy, Tolerability, and Biomarker Analyses of Once-Every-2-Weeks Cetuximab Plus First-Line FOLFOX or FOLFIRI in Patients With KRAS or All RAS Wild-Type Metastatic Colorectal Cancer: The Phase 2 APEC StudyAnn-Lii Cheng, Gerardo Cornelio, Lin Shen, et al.
Pageof 5